Target Name: MIR4279
NCBI ID: G100422874
Other Name(s): hsa-miR-4279 | MicroRNA 4279 | hsa-mir-4279 | microRNA 4279

MIR4279: A Drug Target / Disease Biomarker

MIR4279 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the superfamily of transmembrane protein (SMP) and is characterized by the presence of a long extracellular domain and a short intracellular domain.

One of the unique features of MIR4279 is its ability to interact with multiple intracellular signaling pathways, including the TGF-β pathway, the Wnt pathway, and theNotch pathway. This makes MIR4279 a promising drug target for a variety of diseases.

MIR4279 has also been shown to play a role in several diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. For example, studies have shown that MIR4279 is overexpressed in several types of cancer, including breast, ovarian, and prostate cancer. This suggests that targeting MIR4279 may be a useful way to treat these diseases.

In addition to its role in disease, MIR4279 has also been shown to be a potential biomarker. The ability of MIR4279 to interact with multiple signaling pathways makes it a promising candidate for use as a therapeutic target. This can be useful for the development of new diagnostic tests and for the evaluation of the effectiveness of potential drugs.

One of the challenges in studying MIR4279 is its high level of expression in a variety of tissues, which can make it difficult to study its effects in specific contexts. However, researchers are continuing to delve into the role of MIR4279, and new studies are providing more insights into its biology and potential as a drug target.

In conclusion, MIR4279 is a protein that has the potential to be a drug target or biomarker. Its ability to interact with multiple signaling pathways and its high level of expression in a variety of tissues make it a promising candidate for study. Further research is needed to fully understand its role in disease and its potential as a therapeutic target.

Protein Name: MicroRNA 4279

More Common Targets

MIR4280 | MIR4281 | MIR4282 | MIR4283-1 | MIR4283-2 | MIR4284 | MIR4285 | MIR4286 | MIR4287 | MIR4288 | MIR4289 | MIR429 | MIR4290 | MIR4291 | MIR4292 | MIR4293 | MIR4294 | MIR4295 | MIR4296 | MIR4297 | MIR4298 | MIR4299 | MIR4300 | MIR4300HG | MIR4301 | MIR4302 | MIR4303 | MIR4304 | MIR4305 | MIR4306 | MIR4307 | MIR4308 | MIR4309 | MIR431 | MIR4310 | MIR4311 | MIR4312 | MIR4313 | MIR4314 | MIR4315-1 | MIR4315-2 | MIR4316 | MIR4317 | MIR4318 | MIR4319 | MIR432 | MIR4320 | MIR4321 | MIR4322 | MIR4323 | MIR4324 | MIR4325 | MIR4326 | MIR4327 | MIR4328 | MIR4329 | MIR433 | MIR4330 | MIR4418 | MIR4420 | MIR4423 | MIR4425 | MIR4427 | MIR4428 | MIR4429 | MIR4430 | MIR4431 | MIR4432 | MIR4432HG | MIR4433A | MIR4433B | MIR4435-1 | MIR4435-2 | MIR4435-2HG | MIR4436A | MIR4436B1 | MIR4436B2 | MIR4437 | MIR4440 | MIR4441 | MIR4442 | MIR4443 | MIR4444-1 | MIR4444-2 | MIR4445 | MIR4446 | MIR4447 | MIR4448 | MIR4449 | MIR4450 | MIR4451 | MIR4453 | MIR4453HG | MIR4454 | MIR4455 | MIR4456 | MIR4457 | MIR4458 | MIR4458HG | MIR4463